1. Home
  2. GBX vs VCEL Comparison

GBX vs VCEL Comparison

Compare GBX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

N/A

Current Price

$52.35

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$33.21

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GBX
VCEL
Founded
1974
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
GBX
VCEL
Price
$52.35
$33.21
Analyst Decision
Sell
Strong Buy
Analyst Count
2
5
Target Price
$49.00
$58.50
AVG Volume (30 Days)
205.9K
527.5K
Earning Date
04-07-2026
05-07-2026
Dividend Yield
2.55%
N/A
EPS Growth
28.02
60.00
EPS
1.14
0.32
Revenue
$3,240,200,000.00
$276,259,000.00
Revenue This Year
N/A
$19.10
Revenue Next Year
$1.64
$17.95
P/E Ratio
$44.02
$98.34
Revenue Growth
N/A
16.45
52 Week Low
$37.77
$29.24
52 Week High
$59.19
$48.75

Technical Indicators

Market Signals
Indicator
GBX
VCEL
Relative Strength Index (RSI) 44.71 44.56
Support Level $44.64 $31.24
Resistance Level $54.15 $38.48
Average True Range (ATR) 1.41 1.36
MACD -0.41 0.01
Stochastic Oscillator 39.02 52.77

Price Performance

Historical Comparison
GBX
VCEL

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: